1.
Vachhani P, Tan P, Watson A-M, Wu S-J, Baker R, Cheung S, Lee S-E, Chen C-C, Chen T-Y, Hsiao H-H, Lee JH, Masarova L, Tan SY, Baskar J, Charlton B, Findlay A, Hamprecht D, Jarolimek W, Leadbetter J, Miller J, Morgan K, Zahoor A, Hobbs G. A phase I/IIa trial of PXS-5505, a novel pan-lysyl oxidase inhibitor, in advanced myelofibrosis. Haematologica 2025;110(10):2376-2387; https://doi.org/10.3324/haematol.2024.287231.